Ziprax 100mg Dry Syrup Strawberry contains Cefixime, a third-generation cephalosporin antibiotic, at a concentration of 100mg per 5ml. It is indicated for the treatment of a variety of bacterial infections caused by susceptible organisms, including respiratory tract infections, urinary tract infections, otitis media, pharyngitis, and gonorrhea. Cefixime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The dry syrup formulation is designed for pediatric use, offering ease of administration and improved compliance, with a palatable strawberry flavor to enhance acceptability among children. Ziprax is typically administered orally after reconstitution with water, with dosing adjusted according to the severity of infection, patient age, and weight. It is important to complete the full prescribed course to prevent the development of resistance. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, require immediate medical attention. Ziprax should be used cautiously in patients with a history of penicillin or cephalosporin allergy. Renal function monitoring is advised in patients with impaired kidney function to adjust dosing appropriately. This medication should be stored in a cool, dry place and kept out of reach of children.